Clinical trial
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for…
NCT00382070 · NSABP Foundation Inc, Other · Active, not recruiting
Key facts
| NCT number | NCT00382070 |
|---|---|
| Title | Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer |
| Official title | A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women With Hormone Receptor… |
| Lead sponsor | NSABP Foundation Inc, Other |
| Collaborators | National Cancer Institute (NCI) NIH Novartis Industry |
| Status | Active, not recruiting |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Other |
| Interventions | Letrozole, Placebo |
| Enrollment | 3,966 |
| Start date | Aug 1, 2006 |
| Primary completion | Aug 25, 2016 |
| Completion | Apr 1, 2025 |
| First posted | Sep 28, 2006 |
| Last update posted | Mar 22, 2024 |
| Countries | Canada, Ireland, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: